RxISK blog

Mind Softens Warning about Sexual Side Effects of Antidepressants
September 13, 2021 | 2 Comments
A Birth to Announce
September 6, 2021 | 3 Comments
From The Little Mermaid to Buffy the Vampire Slayer
August 22, 2021 | 11 Comments
Once We Were Warriors Tackling Prescription Drugs
August 16, 2021 | 4 Comments
What’s a life worth? Is anyone listening?
August 9, 2021 | 17 Comments
What Happened to Britney Spears can Happen to You
August 2, 2021 | 4 Comments
Insomnia the Royal Road to Pills and Nightmares
July 26, 2021 | 16 Comments
Forty Winks: Insomnia and Antidepressants
July 19, 2021 | 13 Comments
A Public Service or A Lethal Scam?
July 8, 2021 | 19 Comments
Clinical Trial Fraud
June 28, 2021 | 13 Comments
Ghosts in the Clinical Trial Machine
June 21, 2021 | 17 Comments
The Insomnia Diaries
June 14, 2021 | 18 Comments
Woman holding up a photo of her smile
Antidepressants and Dental Problems
June 6, 2021 | 8 Comments
Coercion, Zyprexa and Psychiatry
June 4, 2021 | 4 Comments
A Roadmap for Fighting Corporate Giants
June 3, 2021 | One Comment
A Legal System for Drug Companies not Patients
June 2, 2021 | One Comment
The Bestselling Zyprexa Papers
June 1, 2021 | One Comment
The Zyprexa Papers: Outing drug company corruption
May 31, 2021 | No Comments
Remember Those Condemned to Swallow
May 28, 2021 | 7 Comments
One Story to Rule them all: From Prozac to Abilify
May 26, 2021 | 6 Comments
A Story of Iatrogenic Insanity: Prescription for Sorrow
May 24, 2021 | 6 Comments
Malcharist: A Spellbinding Thriller 2
May 22, 2021 | 4 Comments
Malcharist: A Spellbinding Thriller
May 21, 2021 | 2 Comments
The Hemingway Effect
May 20, 2021 | 2 Comments
Malcharist: Fact or Fiction?
May 18, 2021 | 8 Comments
Fiction that captures reality: Malcharist
May 17, 2021 | 10 Comments
Farewell Marchino
April 30, 2021 | 100 Comments
Sex, No Sex, Sex, No Sex….
April 21, 2021 | 19 Comments
Medical Assistance in Dying: A Personal Perspective
April 9, 2021 | 17 Comments
Antidepressants: Education and Disability Certificates
March 22, 2021 | 38 Comments